These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 22501017)

  • 21. Deciphering the signaling pathways of cancer stem cells of glioblastoma multiforme: role of Akt/mTOR and MAPK pathways.
    Jhanwar-Uniyal M; Albert L; McKenna E; Karsy M; Rajdev P; Braun A; Murali R
    Adv Enzyme Regul; 2011; 51(1):164-70. PubMed ID: 21035497
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cancer stem-cell signaling network and resistance to therapy.
    Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
    Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Recommendations on the multidisciplinary management in patients with malignant glioma].
    Graus F; Cerdá M; Piquer J; Reynés G; Santos M
    Med Clin (Barc); 2001 Feb; 116(7):271-5. PubMed ID: 11333738
    [No Abstract]   [Full Text] [Related]  

  • 24. Emerging strategies for the treatment of tumor stem cells in central nervous system malignancies.
    Khan IS; Ehtesham M
    Adv Exp Med Biol; 2015; 853():167-87. PubMed ID: 25895712
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [The stem cell niche in glioblastoma: from fundamental aspects to targeted therapies].
    Turpin A; Sharif A; Stoven L; Blond S; Maurage CA; Le Rhun É
    Bull Cancer; 2015 Jan; 102(1):24-33. PubMed ID: 25609493
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The side story of stem-like glioma cells.
    Persson AI; Weiss WA
    Cell Stem Cell; 2009 Mar; 4(3):191-2. PubMed ID: 19265652
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prognostic evaluation of histological criteria in central nervous system astrocytomas: 51 cases].
    Trabelsi S; Haouet S; Mekni A; Bouraoui S; Bellil K; Kchir N; Zitouna MM
    Tunis Med; 2002 May; 80(5):274-7. PubMed ID: 12534032
    [No Abstract]   [Full Text] [Related]  

  • 28. ABCG2: the key to chemoresistance in cancer stem cells?
    An Y; Ongkeko WM
    Expert Opin Drug Metab Toxicol; 2009 Dec; 5(12):1529-42. PubMed ID: 19708828
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MiR-608 inhibits the migration and invasion of glioma stem cells by targeting macrophage migration inhibitory factor.
    Wang Z; Xue Y; Wang P; Zhu J; Ma J
    Oncol Rep; 2016 May; 35(5):2733-42. PubMed ID: 26935642
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EGFR signaling is differentially activated in patient-derived glioblastoma stem cells.
    Howard BM; Gursel DB; Bleau AM; Beyene RT; Holland EC; Boockvar JA
    J Exp Ther Oncol; 2010; 8(3):247-60. PubMed ID: 20734923
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of morphological issues of central nervous system glioblastoma on chicken embryo chorioallantoic membrane.
    Tereseviciūte N; Tamasauskas A; Valanciūte A; Deltuva V; von graf KD
    Pol J Vet Sci; 2007; 10(3):173-8. PubMed ID: 17937190
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification and expansion of human osteosarcoma-cancer-stem cells by long-term 3-aminobenzamide treatment.
    Di Fiore R; Santulli A; Ferrante RD; Giuliano M; De Blasio A; Messina C; Pirozzi G; Tirino V; Tesoriere G; Vento R
    J Cell Physiol; 2009 May; 219(2):301-13. PubMed ID: 19160414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-125b inhibitor may enhance the invasion-prevention activity of temozolomide in glioblastoma stem cells by targeting PIAS3.
    Shi L; Wan Y; Sun G; Zhang S; Wang Z; Zeng Y
    BioDrugs; 2014 Feb; 28(1):41-54. PubMed ID: 23857508
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and significance of ABCG2 in human malignant glioma].
    Chu L; Huang Q; Zhai DZ; Zhu Q; Huo HM; Dong J; Qian ZY; Wang AD; Lan Q; Gao YL
    Ai Zheng; 2007 Oct; 26(10):1090-4. PubMed ID: 17927879
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Requirement of ABC transporter inhibition and Hoechst 33342 dye deprivation for the assessment of side population-defined C6 glioma stem cell metabolism using fluorescent probes.
    Murota Y; Tabu K; Taga T
    BMC Cancer; 2016 Nov; 16(1):847. PubMed ID: 27814696
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of cancer stem cells in glioblastoma.
    Sundar SJ; Hsieh JK; Manjila S; Lathia JD; Sloan A
    Neurosurg Focus; 2014 Dec; 37(6):E6. PubMed ID: 25434391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immune Checkpoint Modulators: An Emerging Antiglioma Armamentarium.
    Kim ES; Kim JE; Patel MA; Mangraviti A; Ruzevick J; Lim M
    J Immunol Res; 2016; 2016():4683607. PubMed ID: 26881264
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Stem cells of ependymoma.
    Poppleton H; Gilbertson RJ
    Br J Cancer; 2007 Jan; 96(1):6-10. PubMed ID: 17179988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional roles of enhancer of zeste homolog 2 in gliomas.
    Yin Y; Qiu S; Peng Y
    Gene; 2016 Jan; 576(1 Pt 2):189-94. PubMed ID: 26435191
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Twist1 and Snail link Hedgehog signaling to tumor-initiating cell-like properties and acquired chemoresistance independently of ABC transporters.
    Kong Y; Peng Y; Liu Y; Xin H; Zhan X; Tan W
    Stem Cells; 2015 Apr; 33(4):1063-74. PubMed ID: 25588661
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.